Device brand name · Self expanding stent system
Absolute Pro Vascular Self-Expanding Stent System: medical device reports filed with FDA
520 reports name it, 2012–2024. Manufacturer given most often on reports: Av-Temecula-Ct. Product code NIO.
- 520
- device reports naming the brand
- 0% of all MAUDE reports · about 37 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 60.4%
- classified as malfunction
- 54.5% across the product code
- 1%
- classified as death, as reported
- 5 reports · not verified by FDA
FDA's MAUDE database holds 520 reports that name the brand "Absolute Pro Vascular Self-Expanding Stent System" (self expanding stent system), received between April 2012 and May 2024; the manufacturer given most often on reports is Av-Temecula-Ct. Spellings of one product vary from report to report.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (60.4%), injury (38.7%) and death (1%); across all stent, iliac reports (product code NIO) death is recorded in 2.9% and malfunction in 54.5%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are premature activation (18.7%), difficult to remove (13.8%) and improper or incorrect procedure or method (12.9%). The patient problems coded most often are no patient involvement, foreign body in patient and hypersensitivity/allergic reaction. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 7,265 reports carrying product code NIO. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Premature activation | 97 | 18.7% | 7.5% |
| Difficult to removethe device was hard to remove | 72 | 13.8% | 10.2% |
| Improper or incorrect procedure or method | 67 | 12.9% | 5.3% |
| Activation failure | 50 | 9.6% | 5.8% |
| Mechanical jam | 46 | 8.8% | 3.2% |
| Breakthe device broke | 45 | 8.7% | 3.6% |
| Difficult or delayed positioning | 45 | 8.7% | 5% |
| Difficult or delayed activation | 39 | 7.5% | 1.7% |
| Material deformation | 36 | 6.9% | 5.8% |
| Device contaminated during manufacture or shipping | 27 | 5.2% | 0.4% |
| Difficult to advance | 27 | 5.2% | 4.2% |
| Physical resistance/sticking | 27 | 5.2% | 1.5% |
| Positioning failure | 26 | 5% | 3.4% |
| Device damaged by another device | 25 | 4.8% | 1.1% |
| Inaccurate delivery | 25 | 4.8% | 1.9% |
| Material separation | 24 | 4.6% | 2.3% |
| Difficult to position | 22 | 4.2% | 2.1% |
| Detachment of device component | 21 | 4% | 1.2% |
| Failure to advance | 21 | 4% | 5.8% |
| Tear, rip or hole in device packaging | 20 | 3.8% | 0.3% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| No patient involvement | 90 | 17.3% |
| Foreign body in patientpart of a device left in the patient | 39 | 7.5% |
| Hypersensitivity/allergic reaction | 11 | 2.1% |
| Stenosis | 11 | 2.1% |
| Painpain, site not specified | 10 | 1.9% |
| Device embedded in tissue or plaque | 7 | 1.3% |
| Vessel or plaque, device embedded in | 7 | 1.3% |
| Thrombosis | 6 | 1.2% |
| Claudication | 5 | 1% |
| Perforation | 5 | 1% |
| Embolism/embolus | 4 | 0.8% |
| Intimal dissection | 4 | 0.8% |
| Myocardial infarctionheart attack | 4 | 0.8% |
| Deaththe patient died; cause not stated by this term | 3 | 0.6% |
| Failure of implant | 3 | 0.6% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Absolute Pro Vascular Self-Expanding Stent System | Product code NIO | All MAUDE reports |
|---|---|---|---|
| Reports | 520 | 7,265 | 26,136,888 |
| Share of that pool | — | 7.2% | 0% |
| Classified as death, per 1,000 reports | 10 | 29 | 9 |
| Classified as injury | 38.7% | 42.3% | 36.2% |
| Classified as malfunction | 60.4% | 54.5% | 62.3% |
| Filed by the manufacturer | 99.8% | 98.7% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code NIO
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Omnilink Elite Peripheral Stent System | 841 | 0 | 0.6% |
| Smart Control Nitinol Stent System | 1,438 | 0 | 1.7% |
| Epic? Vascular | 454 | 18 | 1.8% |
| E-Luminexx Vascular Stent | 472 | 32 | 5.1% |
| Express LD Iliac / Biliary | 420 | 15 | 1.4% |
| Epic | 429 | 32 | 1.2% |
| Complete Se Iliac | 341 | 0 | 5% |
| Omnilink Elite | 263 | 115 | 2.3% |
| Advanta V12 Covered Stent | 340 | 0 | 12.6% |
| Absolute Pro | 252 | 136 | 1.6% |
| Visi-Pro Balloon-Expandable Stent System | 319 | 24 | 4.1% |
| Zilver Flex 35 Vascular Self-Expanding Stent | 203 | 23 | 0.5% |
| GORE VIABAHN VBX Balloon Expandable Endoprosthesis | 1,485 | 295 | 4.9% |
| Assurant Cobalt | 169 | 0 | 1.2% |
| Absolute Pro .035 Self Expanding Stent System | 858 | 38 | 0.2% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Absolute Pro Vascular Self-Expanding Stent System reports
How many FDA reports name Absolute Pro Vascular Self-Expanding Stent System?
520 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
malfunction (60.4%), injury (38.7%) and death (1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
premature activation (18.7%), difficult to remove (13.8%), improper or incorrect procedure or method (12.9%), activation failure (9.6%) and mechanical jam (8.8%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (99.8%) and voluntary reports (0.2%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Absolute Pro Vascular Self-Expanding Stent System was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.